1 Matching Annotations
  1. Oct 2021
  2. www.thelancet.com www.thelancet.com
    Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
    1
    1. forbriger 03 Oct 2021

      Emary, K. R. W., Golubchik, T., Aley, P. K., Ariani, C. V., Angus, B., Bibi, S., Blane, B., Bonsall, D., Cicconi, P., Charlton, S., Clutterbuck, E. A., Collins, A. M., Cox, T., Darton, T. C., Dold, C., Douglas, A. D., Duncan, C. J. A., Ewer, K. J., Flaxman, A. L., … Pollard, A. J. (2021). Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. The Lancet, 0(0). https://doi.org/10.1016/S0140-6736(21)00628-0

      https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00628-0/fulltext

      is:article lang:en COVID-19 efficacy vaccine variant 202012/01 B.1.1.7 ChAdOx1 nCov-19 AZD1222 analysis cause UK MenACWY symptom NAAT nucleic acid amplification antibody modeling exploratory
    Visit annotations in context

    Tags

    Annotators

    URL

    thelancet.com/journals/lancet/article/PIIS0140-6736(21)00628-0/fulltext